...
首页> 外文期刊>The Journal of extra-corporeal technology >Extracorporeal membrane oxygenation as a platform for recovery: A case report of a child with pulmonary hemorrhage, refractory hypoxemic respiratory failure, and new onset goodpasture syndrome
【24h】

Extracorporeal membrane oxygenation as a platform for recovery: A case report of a child with pulmonary hemorrhage, refractory hypoxemic respiratory failure, and new onset goodpasture syndrome

机译:体外膜氧合作用作为康复平台:一名儿童发生肺出血,难治性低氧血症性呼吸衰竭和新发病的好手综合征的病例报告

获取原文
获取原文并翻译 | 示例

摘要

We report a case of a 9-year-old female with acute pulmonary hemorrhage and refractory hypoxemic respiratory failure secondary to Goodpasture syndrome (GS). After failing treatment with high frequency oscillatory ventilation and inhaled nitric oxide, she was successfully managed with venovenous extracorporeal membrane oxygenation (VV ECMO). The patient's weight at the time of cannulation was 31 kg. A 19 French 18 cm (arterial) Biomedicus cannula was inserted in the right internal jugular vein and used as the drain. A 17 French 50 cm (venous) Biomedicus cannula was inserted in the right femoral vein and used as the return. Then the patient was anticoagulated with 100 units/kg of intravenous heparin and the circuit was primed with one unit of packed red blood cells. VV ECMO was performed with an SIII Sorin roller head pump with integrated servo regulator and a Quadrox D Bioline coated oxygenator. Despite systemic anticoagulation with heparin, the patient's pulmonary hemorrhage resolved. Extracorporeal membrane oxygenation served as a platform through which we were able to provide renal replacement therapy and plasmapheresis. The patient was successfully discharged home with normal pulmonary function.
机译:我们报告了一例9岁女性,患有继发于Goodpasture综合征(GS)的急性肺出血和难治性低氧血症性呼吸衰竭。在高频振荡通气和吸入一氧化氮治疗失败后,她成功地接受了静脉静脉体外膜氧合(VV ECMO)治疗。插管时患者的体重为31 kg。在右颈内静脉中插入一个19法式18厘米(动脉)生物医学插管,并用作引流管。将一根17法语的50厘米(静脉)生物医学插管插入右股静脉,用作回输管。然后用100单位/ kg的静脉肝素对患者进行抗凝,并用1单位填充的红细胞灌注回路。 VV ECMO使用带有集成伺服调节器和Quadrox D Bioline涂层充氧器的SIII Sorin辊头泵进行。尽管使用肝素进行全身抗凝治疗,但患者的肺出血得以解决。体外膜氧合作用是我们能够提供肾脏替代疗法和血浆置换的平台。该患者已成功出院,肺功能正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号